Compare Sangal Papers with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 6.69%
- Poor long term growth as Net Sales has grown by an annual rate of 13.86% and Operating profit at 18.76% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.33 times
Flat results in Dec 25
38.76% of Promoter Shares are Pledged
Underperformed the market in the last 1 year
Stock DNA
Paper, Forest & Jute Products
INR 23 Cr (Micro Cap)
13.00
18
0.00%
0.57
4.14%
0.53
Total Returns (Price + Dividend) 
Sangal Papers for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Sangal Papers Ltd Downgraded to Strong Sell Amidst Weak Fundamentals and Flat Financials
Sangal Papers Ltd, a micro-cap player in the Paper, Forest & Jute Products sector, has seen its investment rating downgraded from Sell to Strong Sell as of 23 March 2026. Despite an improvement in valuation metrics, the company’s weak financial trends and deteriorating quality scores have weighed heavily on its overall assessment, prompting a cautious stance among investors.
Read full news article
Sangal Papers Ltd Valuation Shifts to Attractive Amid Mixed Market Performance
Sangal Papers Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive price level, despite a recent downgrade in its overall mojo grade to Strong Sell. This article analyses the changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors amid the company’s mixed financial performance and micro-cap status.
Read full news article
Sangal Papers Ltd Valuation Shifts Signal Renewed Price Attractiveness
Sangal Papers Ltd, a micro-cap player in the Paper, Forest & Jute Products sector, has seen its valuation parameters shift notably, moving from very attractive to attractive territory. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling price point relative to peers and historical averages, warranting a closer examination of its valuation and market performance.
Read full news article Announcements 
Closure of Trading Window
20-Mar-2026 | Source : BSEIntimation of Closure of Trading Window from 1st April 2026 till 48 hours of declaration of Audited Financial results for the quarter and year ended 31.03.2026.
Announcement under Regulation 30 (LODR)-Meeting Updates
06-Mar-2026 | Source : BSEOutcome of Meeting of Independent Directors held on 06.03.2026.
Announcement Under Regulation 30 Of SEBI(LODR) Regulations2015.
05-Mar-2026 | Source : BSEAnnouncement under Regulation 30 of SEBI(LODR) Regulations2015 regarding resumption of Production activities w.e.f 04/03/2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
38.7565
Held by 0 Schemes
Held by 0 FIIs
Amit Sangal (9.26%)
Mahendra Girdharilal (2.72%)
58.5%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -3.41% vs 1.64% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 16.67% vs -62.50% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 2.27% vs -2.40% in Sep 2024
Growth in half year ended Sep 2025 is -50.22% vs 384.78% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 6.87% vs -5.80% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -39.17% vs 49.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -5.29% vs -15.82% in Mar 2024
YoY Growth in year ended Mar 2025 is 14.57% vs -27.14% in Mar 2024






